Summary
Acambis shuts and opens in Cambridge
SMALLPOX vaccine maker Acambis is to close its Cambridge, England, research laboratory and move all research to Cambridge, Massachusetts, at the cost of 40 British jobs. Acting chief executive Gordon Cameron said the rationalisation would help "deliver the maximum value to our shareholders".See the full content of this document
Extract
In Brief
Aberdeen trust ...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
Milestone Will Mean Nothing Without Cups, Says Rooney [Edition 2] | Zola Could Be Forced to Win Ugly | Peer Wins C-Charge Battle | Nigel Pizey's Film of the Week ; Sleepy Hollow | Senate Provides Some Pension Funding Relief | Glenpool-Based Us Highland to Restructure Management Team | William J Walsh Jr. | Attorney General Wants Same-Sex Unions to Resume
